title: Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ion.
abstract: Voltage-gated potassium channels (Kv) are targets for drugs of large chemical diversity. Although hydrophobic cations block Kv channels with Hill coefficients of 1, uncharged electron-rich (cationophilic) molecules often display Hill coefficients of 2. The mechanism of the latter block is unknown. Using a combination of computational and experimental approaches, we mapped the receptor for the immunosuppressant PAP-1 (5-(4-phenoxybutoxy)psoralen), a high-affinity blocker of Kv1.3 channels in lymphocytes. Ligand-docking using Monte Carlo minimizations suggested a model in which two cationophilic PAP-1 molecules coordinate a K(+) ion in the pore with their coumarin moieties, whereas the hydrophobic phenoxyalkoxy side chains extend into the intrasubunit interfaces between helices S5 and S6. We tested the model by generating 58 point mutants involving residues in and around the predicted receptor and then determined their biophysical properties and sensitivity to PAP-1 by whole-cell patch-clamp. The model correctly predicted the key PAP-1-sensing residues in the outer helix, the P-loop, and the inner helix and explained the Hill coefficient of 2 by demonstrating that the Kv1.3 pore can accommodate two or even four PAP-1 molecules. The model further explained the voltage-dependence of block by PAP-1 and its thousand-fold selectivity for Kv1.3 over non-Kv1 channels. The 23- to 125-fold selectivity of PAP-1 for Kv1.3 over other Kv1 channels is probably due to its preferential affinity to the C-type inactivated state, in which cessation of K(+) flux stabilizes the tripartite PAP-1:K(+):PAP-1 complex in the pore. Our study provides a new concept for potassium channel block by cationophilic ligands.
authors.affiliation: Department of Pharmacology, University of California, Davis, California, USA.
authors.forename: Pavel I
authors.initials: PI
authors.lastname: Zimin
authors.forename: Bojan
authors.initials: B
authors.lastname: Garic
authors.forename: Silke B
authors.initials: SB
authors.lastname: Bodendiek
authors.forename: Cédrick
authors.initials: C
authors.lastname: Mahieux
authors.forename: Heike
authors.initials: H
authors.lastname: Wulff
authors.forename: Boris S
authors.initials: BS
authors.lastname: Zhorov
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002412:Cations; D002460:Cell Line; D006801:Humans; D051664:Kv1.3 Potassium Channel / Q000037:antagonists & inhibitors* / Q000502:physiology; D008024:Ligands; D051379:Mice; D008969:Molecular Sequence Data; D000073718:Pancreatitis-Associated Proteins; D011188:Potassium / Q000737:chemistry* / Q000494:pharmacology; D026902:Potassium Channel Blockers / Q000737:chemistry* / Q000494:pharmacology*; D024642:Potassium Channels, Voltage-Gated / Q000037:antagonists & inhibitors / Q000502:physiology; D017433:Protein Structure, Secondary
chemical_list: D002412:Cations; D051664:Kv1.3 Potassium Channel; D008024:Ligands; D000073718:Pancreatitis-Associated Proteins; D026902:Potassium Channel Blockers; D024642:Potassium Channels, Voltage-Gated; C000612141:REG3A protein, human; D011188:Potassium